A health disparities study of MicroRNA-146a expression in prostate cancer samples derived from African American and European American patients
Journal of Solid Tumors · 2020
DOI: 10.5430/jst.v10n2p1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Solid Tumors, 2020. Verfasst von Monet Stevenson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Natural,Pharmacy and Health, Elizabeth City State University/University of North Carolina, Elizabeth, United States. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Considering the prevalence of prostate cancer all over the world, it is desired to have tools, technologies, and biomarkers which help in early detection of the disease and discriminate different races and ethnic groups. Genetic information from the single gene analysis and genome-wide association studies have identified few biomarkers, however, the drivers of prostate cancer remain unknown in the majority of prostate cancer patients. In those cases where genetic association has been identified, the genes confer only a modest risk of this cancer, hence, making them less relevant for risk counseling and disease management. There is a need for additional biomarkers for diagnosis and prognosis of prostate cancer. MicroRNAs are a class of non-protein coding RNA molecules that are frequently dysregulated in different cancers including prostate cancer and show promise as diagnostic biomarkers and targets for therapy. Here we describe the role of micro RNA 146a (miR-146a) which may serve as a diagnostic and prognostic marker for prostate cancer, as indicated from the data presented in this report. Also, a pilot study indicated differential expression of miR-146a in prostate cancer cell lines and tissues from different racial groups. Reduced expression of miR-146a was observed in African American tumor tissues compared to those from European Whites This report provides a novel insight into understanding the prostate carcinogenesis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Natural,Pharmacy and Health, Elizabeth City State University/University of North Carolina, Elizabeth, United States.
- Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Suite 4E102, 9609 Medical Center Drive, Bethesda, United States.
- Department of Pathology, Wayne State University and Barbara Karmanos Cancer Center, Detroit, United States.
- Department of Chemistry, Morgan State University, Baltimore, United States.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Stevenson, M., Nath Banerjee, H., Banerjee, N., Rawat, K., Chen, L., Worthington, M., Hodge, S., Walker, R., Verma, M., Sarkar, F., & Mandal, S. (2020). A health disparities study of MicroRNA-146a expression in prostate cancer samples derived from African American and European American patients. Journal of Solid Tumors. https://doi.org/10.5430/jst.v10n2p1
Vancouver
Stevenson M, Nath Banerjee H, Banerjee N, Rawat K, Chen L, Worthington M, et al. A health disparities study of MicroRNA-146a expression in prostate cancer samples derived from African American and European American patients. Journal of Solid Tumors. 2020. doi:10.5430/jst.v10n2p1
BibTeX
@article{Stevenson2020,
author = {Stevenson, Monet and Nath Banerjee, Hirendra and Banerjee, Narendra and Rawat, Kuldeep and Chen, Lin and Worthington, Myla and Hodge, Sasha and Walker, Rayshawn and Verma, Mukesh and Sarkar, Fazlul and Mandal, Santosh},
title = {A health disparities study of MicroRNA-146a expression in prostate cancer samples derived from African American and European American patients},
journal = {Journal of Solid Tumors},
year = {2020},
doi = {10.5430/jst.v10n2p1}
}
EUVIMED